Neo Ivy Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-453,138
| Closed | -$3.35M | – | 355 |
|
|
2024
Q4 | $3.35M | Buy |
+453,138
| New | +$3.35M | 0.68% | 61 |
|
|
2024
Q3 | – | Sell |
-212,648
| Closed | -$1.71M | – | 331 |
|
|
2024
Q2 | $1.71M | Buy |
+212,648
| New | +$1.71M | 0.33% | 127 |
|
|
2022
Q2 | – | Sell |
-292
| Closed | -$4K | – | 503 |
|
|
2022
Q1 | $4K | Sell |
292
-2,609
| -90% | -$35.7K | ﹤0.01% | 454 |
|
|
2021
Q4 | $55K | Buy |
+2,901
| New | +$55K | 0.08% | 268 |
|
|
2021
Q2 | – | Sell |
-3,215
| Closed | -$102K | – | 523 |
|
|
2021
Q1 | $102K | Buy |
3,215
+148
| +5% | +$4.7K | 0.11% | 240 |
|
|
2020
Q4 | $142K | Buy |
3,067
+1,549
| +102% | +$71.7K | 0.16% | 204 |
|
|
2020
Q3 | $49K | Buy |
+1,518
| New | +$49K | 0.05% | 363 |
|
|
2020
Q2 | – | Sell |
-693
| Closed | -$21K | – | 520 |
|
|
2020
Q1 | $21K | Buy |
+693
| New | +$21K | 0.03% | 376 |
|